LEUKEMIA DRUG EFFECTIVE FOR RARE BLOOD DISEASE, U PHYSICIAN REPORTS IN THE LANCET

Update Item Information
Title LEUKEMIA DRUG EFFECTIVE FOR RARE BLOOD DISEASE, U PHYSICIAN REPORTS IN THE LANCET
Subject Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Antineoplastic Agents; Academic Medical Centers; Hospitals, University; Public Relations; Communications Media; Mass Media; Social Marketing; Information Dissemination; News; Press Release
Description A drug that effectively treats chronic myelogenous leukemia (CML) in two of three cases works even better against a rare but potentially fatal blood disease, a University of Utah physician reports in the prestigious British medical journal, The Lancet.
Publisher University of Utah Health Care Office of Public Affairs and Marketing
Date 2002-04-29
Language eng
Relation University of Utah Health Care Office of Public Affairs and Marketing Collection
Rights Management Copyright 2012
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Scanning Technician sg
Relation is Part of Press Releases; University of Utah Health Sciences Center News
Type Text
ARK ark:/87278/s69w39fz
Setname ehsl_pahsc
ID 935810
Reference URL https://collections.lib.utah.edu/ark:/87278/s69w39fz
Back to Search Results